Friday, 30 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Indoco Remedies Merger & Restructuring

Indoco Remedies Limited approved the strategic transfer of its ophthalmic division in India and select African territories to Sunways (India) Private Limited. The divestment allows Indoco to focus on core therapeutic areas while Sunways strengthens its specialized ophthalmology platform. The transaction includes an established operating portfolio and manufacturing capabilities.

Source

NSE filing, NSE: INDOCO. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Indoco Remedies Ltd: key numbers

Share price
₹209.50
Market cap
₹1,934 Cr
Revenue (annual)
₹1,845 Cr
Net profit (annual)
₹-95.14 Cr
P/E (TTM)
60.5×Sector 48.7×
Promoter holding
58.92%+0.06% QoQ
FII holding
1.64%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Indoco Remedies Ltd

All →

Other merger & restructuring announcements

All →